Literature DB >> 14226251

EFFECT OF SULFINPYRAZONE ON SERUM URIC ACID IN GOUT. A LONG-TERM STUDY.

W C KUZELL, R P GLOVER, J O GIBBS, R A BLAU.   

Abstract

Entities:  

Keywords:  ADOLESCENCE; AGING; BLOOD; DRUG THERAPY; GERIATRICS; GOUT; METABOLISM; PHENYLBUTAZONE; PROBENECID; SALICYLATES; SEX; SULFINPYRAZONE; TOXICOLOGIC REPORT; URIC ACID

Mesh：

Substances：

Year:  1964        PMID： 14226251

Source DB:  PubMed          Journal:  Geriatrics        ISSN： 0016-867X


× No keyword cloud information.
  3 in total

1.  Pyrazolidines in the treatment of gout.

Authors:  W C Kuzell
Journal:  Can Med Assoc J       Date:  1968-11-30       Impact factor: 8.262

2.  Enhanced drug metabolism after sulfinpyrazone treatment in patients aged 50 to 60 years.

Authors:  E Walter; C Staiger; J de Vries; E Weber; W Bitzer; M Degott; K Jüngling
Journal:  Klin Wochenschr       Date:  1982-11-15

3.  Biotransformation and pharmacokinetics of sulfinpyrazone (Anturan) in man.

Authors:  W Dieterle; J W Faigle; H Mory; W J Richter; W Theobald
Journal:  Eur J Clin Pharmacol       Date:  1975-12-19       Impact factor: 2.953
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.